Logo

GenVault Licenses DNA Labeling Technology from the University of Texas

May 11, 2005

NEW YORK, May 11 (GenomeWeb News) - Genvault has exclusively licensed DNA labeling technology from the Universityof Texas, the San Diego-based company said today.

 

The patent licensed by GenVault, USPatent No. 6, 153,389, covers a technology for labeling biological samples like blood, semen, or saliva for subsequent DNA analysis. It provides a distinctive label for biosamples for future identification, according to GenVault.

 

The patent allows GenVault to offer and license GenCode, its own DNA labeling technology, to a broader market.

Breaking News
The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.